NorthWest Biotherapeutics Inc (NWBO)

[skitahoe]

I'd like to chime in on this. I believe that investors have been waiting so long for the unblinding that no one is certain of when it will happen.

When I first invested over a year ago, many were certain that 36 months after the last patient enrolled it would happen. Some now believe that 48 months is the key. In a trial for a totally different product I saw that they keyed on 49 months, I have no idea what was behind that choice. The point is, investors don't know, and the company is providing little guidance.

Just today I wrote Dave Innis about errors in the website regarding the Phase 3 Trial. I suggested a change wasn't critical if something is happening near term, but if not it should be fixed.

I wouldn't be at all surprised if the company has confidentiality agreements with one, or more potential partners, and that might handcuff them wrt what they can tell investors at this point. Under confidentiality potential partners my be able to see the raw data as soon as the trial is unblinded, even before top line data is announced.

Gary